714.1 USD
-3.37 (-0.47%)
714.1 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to IDXX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 773.18. This target is 8.27% above the current price.
IDXX was analyzed by 22 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IDXX.
In the previous month the buy percentage consensus was at a similar level.
IDXX was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-04 | BTIG | Maintains | Buy -> Buy |
| 2025-11-04 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-04 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-31 | Stifel | Upgrade | Hold -> Buy |
| 2025-10-01 | UBS | Initiate | Neutral |
| 2025-08-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-17 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-07-02 | Stifel | Maintains | Hold -> Hold |
| 2025-06-11 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-05-19 | Stifel | Maintains | Hold -> Hold |
| 2025-05-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-14 | Stifel | Maintains | Hold -> Hold |
| 2025-02-10 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-02-04 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-04 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-01-29 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-12-02 | Leerink Partners | Initiate | Outperform |
| 2024-11-04 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-04 | Piper Sandler | Reiterate | Neutral -> Neutral |
| 2024-10-11 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-10 | Stifel | Maintains | Hold -> Hold |
| 2024-08-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-07-25 | BTIG | Initiate | Buy |
| 2024-06-24 | Stifel | Maintains | Hold -> Hold |
| 2024-05-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-05-02 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-06 | Barclays | Maintains | Overweight -> Overweight |
IDEXX LABORATORIES INC / IDXX FAQ
What is the average price target for IDEXX LABORATORIES INC (IDXX) stock?
22 analysts have analysed IDXX and the average price target is 773.18 USD. This implies a price increase of 8.27% is expected in the next year compared to the current price of 714.1.
How do analysts rate IDEXX LABORATORIES INC (IDXX)?
The consensus rating for IDEXX LABORATORIES INC (IDXX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover IDEXX LABORATORIES INC (IDXX) stock?
The number of analysts covering IDEXX LABORATORIES INC (IDXX) is 22.